Cognition Therapeutics (CGTX) Operating Leases (2022 - 2026)
Cognition Therapeutics (CGTX) reported Operating Leases of $176000.0 for Q1 2026, down 37.14% year-over-year from $280000.0 in Q1 2025, and down 9.74% on a QoQ basis from $195000.0 in Q4 2025.
Cognition Therapeutics (CGTX) has 5 years of Operating Leases data on file, last reported at $176000.0 in Q1 2026.
- Quarterly Operating Leases fell 37.14% year-over-year to $176000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $176000.0 (down 37.14% YoY) and the FY2025 annual result came in at $195000.0, down 42.98% from the prior year.
- Operating Leases fell to $176000.0 in Q1 2026 per CGTX's latest filing, from $195000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $695000.0 in Q4 2022 and bottomed at $176000.0 in Q1 2026.
- The 5-year median for Operating Leases is $440000.0 (2024), against an average of $426235.3.
- The widest annual swing landed in 2023, when Operating Leases soared 50.5%; it then plunged 47.95% in 2025.
- Tracing CGTX's Operating Leases over 5 years: stood at $695000.0 in 2022, then retreated by 25.18% to $520000.0 in 2023, then plunged by 34.23% to $342000.0 in 2024, then sank by 42.98% to $195000.0 in 2025, then slipped by 9.74% to $176000.0 in 2026.
- Per Business Quant, the three latest CGTX Operating Leases figures stand at $176000.0 (Q1 2026), $195000.0 (Q4 2025), and $212000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 176,000.00 |
| Dec 31, 2025 | 195,000.00 |
| Sep 30, 2025 | 212,000.00 |
| Jun 30, 2025 | 229,000.00 |
| Mar 31, 2025 | 280,000.00 |
| Dec 31, 2024 | 342,000.00 |
| Sep 30, 2024 | 392,000.00 |
| Jun 30, 2024 | 440,000.00 |
| Mar 31, 2024 | 488,000.00 |
| Dec 31, 2023 | 520,000.00 |
| Sep 30, 2023 | 565,000.00 |
| Jun 30, 2023 | 608,000.00 |
| Mar 31, 2023 | 651,000.00 |
| Dec 31, 2022 | 695,000.00 |
| Sep 30, 2022 | 603,000.00 |
| Jun 30, 2022 | 404,000.00 |
| Mar 31, 2022 | 446,000.00 |